OR WAIT null SECS
April 08, 2021
Ahmed Bouzidi explores the opportunities and challenges facing small and mid-size biopharma companies as they strive to bring their latest innovations to market.
March 23, 2021
Henry McNamara, Senior Vice President and General Manager, Oracle Health Sciences, reviews the lessons that the industry has learned over the last year and looks at what lies ahead for pharma in 2021.
March 11, 2021
Examining the key biopharma stock numbers and industry trends from a year that challenged the conduct of business and market stability like never before.
Industry makes large investments toward public health issues exposed by pandemic.
Looking back at 1986-1989.
Tracing biopharma’s innovation evolution—and, framed by COVID-19 and the med-tech boon, a look at four notable efforts focused on that one elusive constant: translational value.
March 10, 2021
With the cancellation of most field site visits last year due to the coronovirus pandemic, FDA now faces a serous backlog in inspections both in the US and abroad.
March 08, 2021
Presenting a structured, decision-making approach for executive management to make sound strategic decisions for drug development and life cycle management.
February 18, 2021
Three changes manufacturers should consider in the wake of COVID-19.
February 11, 2021
Looking back at 1982-1985.
